Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind placebo-controlled study of pregabalin extended-release tablets for painful diabetic peripheral neuropathy
CTR20232268Phase 3Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pregabalin in diabetic polyneuropathy (DPN), Neuralgia, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Nov 2023; status: completed.
02
Drugs
pregabalin
03
Conditions
diabetic polyneuropathy (DPN)Neuralgia
Beyond the preview
Go deeper on CTR20232268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232268.